Chemokine CCL5 overexpression combined with radiotherapy modulates Th1-mediated immune response and leads to significant tumor growth delay in mouse tumor models

Download

Authors: Tim Bozic, Iva Santek, Ziva Pisljar, Simona Kranjc Brezar, Gregor Sersa, Bostjan Markelc, and Maja Cemazar

Biomedicine & Pharmacotherapy, 6 January 2026

Related Resources
Exploring Hypofractionated Radiotherapy Efficacy in Prostate Cancer: In Vitro Insights
APR-246 as a radiosensitization strategy for mutant p53 cancers treated with alpha-particles-based radiotherapy
Characterization and application of targeted MnO2/CS@ALA-MTX nano-radiosensitizers for boosting X-ray radiotherapy of brain tumors

Related Products

Axion BioSystems Exact FL cell counter

Exact FL